Osteoarthritis Trial, Recruiting NCT06684587 Sponsor: Boston University Charles River Campus Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT06684587
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 50 years or older who have knee pain related to activity, and either no morning knee stiffness or morning knee stiffness that lasts 30 minutes or less
  • People with a BMI under 40
  • People who have had knee pain on most days for 3 months or longer
  • People whose average knee pain has been rated 4 or higher (on a scale of 0–10) over the past 7 days, measured on at least two occasions at least 2 weeks apart
  • People who are able to attend sessions remotely (for example, via video call)
  • People who can speak and understand English well enough to follow the study procedures and give informed consent
  • People who are available for the full duration of the study

Who may not be able to join:

  • People for whom exercise is medically not recommended
  • People who have pain in their lower back or legs that is worse than their knee pain
  • People who have received physiotherapy for knee osteoarthritis in the past 6 months, or who are currently receiving it
  • People who have taken part in a mindfulness-based program such as Tai Chi or meditation in the past 6 months, or who are currently doing so
  • People currently receiving chemotherapy or radiation therapy for cancer, except for non-melanoma skin cancer treatment
  • People with a history of certain joint diseases affecting the knee, such as rheumatoid arthritis, gout, lupus, ankylosing spondylitis, psoriatic arthritis, knee joint infections, or knee tumours (confirm with trial site for the full list)
  • People who have had knee surgery in the past 6 months
  • People who have had a joint replacement in either hip or ankle
  • People who have previously had a partial or total knee replacement, or a knee bone-reshaping surgery (osteotomy) in either knee
  • People who have a major knee treatment planned during the study, such as surgery, injections, or physiotherapy
  • People who have major surgery planned in the next 6 months
  • People who have had corticosteroid or hyaluronic acid injections in either knee within the past 3 months
  • People with a neurological condition that affects movement, such as stroke, Parkinson's disease, Alzheimer's disease, multiple sclerosis, or diabetic nerve damage
  • People who are pregnant
  • People currently taking part in another clinical trial for any joint or muscle pain
  • People with known or suspected drug or alcohol misuse

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 617-358-3037

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Boston University Charles River Campus
Registry
ClinicalTrials.gov
Start date
24 April 2025
Est. completion
1 April 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Recruitment Rate; Attendance; Retention Rate; Adverse and serious adverse events

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov